BeStock  
Markets › Compare › GPCR vs MLYS

GPCR vs MLYS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GPCR · Structure Therapeutics$27.59 ▼ 0.29%
MLYS · Mineralys Therapeutics$23.30 ▼ 1.40%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

44119195271346Oct 7, '25Apr 7, '26Oct 5, '26
  • GPCR -2.9%
  • MLYS -38.1%

Head to head

MetricGPCRMLYS
Price$27.59$23.30
Change today▼ 0.29%▼ 1.40%
Market cap$1.97B$2.06B
Return, 3 months-51.3%-23.5%
Return, year to date-60.3%-35.8%
Return, 1 year-3.8%-38.7%
P/E (TTM)-9.1-5.5
P/B1.53.7
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-72.2%+13.0%
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+283.6%+118.9%
Analyst buy share100%100%
RSI (14)1734
30-day volatility64.9%67.5%
Max drawdown, 1 year-70.6%-52.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MLYS is the largest of the group by market value.
  • GPCR has returned the most over the past year.
  • GPCR carries the lowest trailing P/E.
  • GPCR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top